Daxor (DXR)
Daxor Revenues: 0.3698M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DXR Revenues Rankings
| Overall | 1st percentile | 4356 of 4425 |
| Sector | 7th percentile | 437 of 470 in Healthcare |
| Industry | 4th percentile | 64 of 67 in Medical Instruments & Supplies |
DXR Revenues Range, Past 5 Years
| Minimum | 0.3323M | Dec 2008 |
| Maximum | 0.5566M | Jun 2008 |
| Average | 0.4126M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these DXR related companies
DXR News
UPDATE: Daxor Announces That Shertech Pharmacy Acquires 2nd BVA-100 Blood Volume Analyzer
Mar 23, 2:00PM Marketwire
Mar 23, 2:00PM Marketwire
Daxor Announces That Shertech Pharmacy Acquires BVA-100 Blood Volume Analyzer
Mar 23, 10:30AM Benzinga
Mar 23, 10:30AM Benzinga
(NYSE Amex: DXR) Daxor Announces Filing of Two Additional Patents for Updated Automated Blood Analyzer
Mar 09, 8:30AM Marketwire
Mar 09, 8:30AM Marketwire
Daxor Announces That the Mayo Clinic in Scottsdale, Arizona Acquires BVA-100 Blood Volume Analyzer
Jan 12, 10:00AM Marketwire
Jan 12, 10:00AM Marketwire
Daxor Announces That the VA Medical Center in Washington, D.C. Acquires BVA-100 Blood Volume Analyzer
Dec 13, 11:00AM Marketwire
Dec 13, 11:00AM Marketwire
Daxor announces that Harborview Medical acquires BVA-100 blood volume analyzer
Nov 22, 8:33AM FlyOnTheWall
Nov 22, 8:33AM FlyOnTheWall
Daxor Announces That Harborview Medical Center of Seattle, WA Acquires BVA-100 Blood Volume Analyzer
Nov 22, 8:30AM Marketwire
Nov 22, 8:30AM Marketwire
Daxor announces that Hartford Hospital acquires BVA-100 blood volume analyzer
Jun 16, 9:57AM FlyOnTheWall
Jun 16, 9:57AM FlyOnTheWall
Looking through lists still, $DXR looking VERY attractive at a 5.54 P/E, 2.55 EPS, and a dividend yield of 7.7%
about 956 days ago by MOFinancial
about 956 days ago by MOFinancial
$DXR still has $18 cash per share and a 6.5% dividend. Unfortunately I was too stupid to hold it last week. Impatience is death to a trader
about 1303 days ago by ShortBusTrader
about 1303 days ago by ShortBusTrader
MSN Money Show: Some cool stock ideas/timing from ppl at stocktwits.com $dxr $sso http://wsmco.com
about 1309 days ago by wsmco
about 1309 days ago by wsmco
$DXR has $77 Million in Short term investments, market cap is $65 Million. paying a 6.7% dividend, health care company, low debt. value ?
about 1309 days ago by ShortBusTrader
about 1309 days ago by ShortBusTrader
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DXR | 8.95 | -0.10 | -1.10% | 37.68M |
| DXPE | 47.71 | +0.87 | +1.86% | 674.14M |
| DXCM | 10.79 | +0.30 | +2.86% | 729.73M |
| DOW | 31.30 | -0.25 | -0.79% | 37.10B |
| DOVR | 4.37 | +0.07 | +1.63% | 23.12M |
| DOV | 57.78 | -0.47 | -0.81% | 10.62B |
| DORM | 48.04 | +1.37 | +2.94% | 866.64M |
| DOO | 36.99 | -0.15 | -0.40% | |
| DON | 53.33 | -0.04 | -0.07% | |
| DOM | 8.05 | -1.18 | -12.78% | 63.19M |
